美能注射液治疗玫瑰糠疹48例临床观察  

Observation of clinical efficacy of Stronger Neo-Minophagen C(SNMC) in the treatment of pityriasis rosea

作　　者：王然[1] 蔡宏为[1] 董琛[1] 

机构地区：[1]中山大学附属第五医院皮肤科,广东珠海519000

出　　处：《广东药学院学报》2006年第1期105-106,共2页Academic Journal of Guangdong College of Pharmacy

摘　　要：目的观察美能注射液治疗玫瑰糠疹的临床疗效。方法80例患者被随机分为治疗组48例和对照组32例,对照组口服氯雷他定、维乐生片、复方蒲公英片治疗,治疗组在此治疗的基础上应用美能注射液40 mL/d静脉滴注。结果治疗组总有效率为77.1%,对照组总有效率为53.1%,两组比较差异有显著性(P<0.05)。结论美能治疗玫瑰糠疹疗效较好,值得临床推广应用。Objective To observe the clinical efficacy of SNMC （Stronger Neo-Minophagen C） in treatment of Pityriasis rosea. Methods Eighty patients were randomly divided into therapeutic and control groups. Tirty-two control patients were treated with Loratadine, compound Vitamine B, and Mongolian dandelion herb tablets. Another forty-eight patients were injected with SNMC （Stronger Neo- Minophagen C） 40ml/d based on the treatment of control groups. Results The general efficacy rate of therapeutic groups is 77.1%, whereas that in control groups is 53.1% （ P 〈 0.05 ）. Conclusion SNMC （ Stronger Neo-Minophagen C ） presented a satisfying and reliable efficacy in the treatment of Pityriasis rosea.

关 键 词：玫瑰糠疹 美能注射液 临床分析 

分 类 号：R758.64[医药卫生—皮肤病学与性病学]